Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study [Phase 2]
Phase II randomized trial evaluating pressurized intraperitoneal aerosol chemotherapy (PIPAC) in gastric carcinomatosis due to gastric adeno…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma [Phase 1, Phase 2]
Update on AK104, a PD-1/CTLA-4 bispecific antibody, evaluated in Phase 1/2 for advanced solid tumors and as first-line therapy with mXELOX/X…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer [Phase 1]
Phase 1 trial evaluating the combination of ramucirumab and pembrolizumab in gastric/GEJ adenocarcinoma, non-small cell lung cancer, urothel…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Stomach Cancer Exosome-based Detection
A clinical trial evaluating an exosome-based detection method for gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 trial of ramucirumab plus irinotecan in previously treated advanced gastric or gastroesophageal junction adenocarcinoma has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma [Phase 2]
Phase II neoadjuvant pembrolizumab trial for early-stage gastroesophageal junction, gastric, and esophageal adenocarcinoma has been terminat…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer [NA]
This completed clinical trial evaluated the effects of probiotic supplementation on the intestinal microbiota of patients with gastric cance…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma [Phase 3]
Clinical trial update for a Phase 3 study evaluating D2 resection with hyperthermic intraperitoneal chemoperfusion (HIPEC) in locally advanc…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for derazantinib alone or with paclitaxel, ramucirumab, or atezolizumab in gastric adenocarcinoma; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC [Phase 2]
Phase 2 trial update evaluating first-line apatinib combined with tislelizumab and chemotherapy for advanced gastric adenocarcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma [Phase 1]
Phase 1 trial updating TAS-102 combined with irinotecan in second-line or higher gastric and gastroesophageal adenocarcinoma; study complete…
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: Adebrelimab Combined With SOX Regimen in Preoperative Neoadjuvant Transformation Therapy for Locally Advanced Gastric Adenocarcinoma [Phase 4]
Phase 4 trial update exploring Adebrelimab combined with SOX as neoadjuvant therapy for locally advanced gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma [Phase 2]
Phase 2 trial investigating Envafolimab in combination with chemotherapy for metastatic or recurrent gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas [Phase 2]
Phase 2 trial of mFOLFOX6 plus trastuzumab and avelumab in gastric and esophageal adenocarcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis [Phase 2]
Phase 2 study evaluating combined intraperitoneal/intravenous paclitaxel with oral capecitabine for gastric adenocarcinoma with peritoneal c…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma [Phase 3]
Phase 3 trial update for CS1001 in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating perioperative leucovorin, oxaliplatin, docetaxel and S-1 (LOTS) for locally advanced gastric or gastroesop…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) [Phase 3]
Phase 3 trial MK-3475-859 (KEYNOTE-859) evaluating pembrolizumab plus chemotherapy versus placebo plus chemotherapy in gastric/GEJ adenocarc…
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer [Phase 2]
Phase II clinical study evaluating surufatinib in combination with sintilimab for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma. [Phase 3]
Phase 3 trial evaluating gentuximab plus paclitaxel versus placebo plus paclitaxel in gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis [Phase 2]
Phase 2 trial of pembrolizumab in advanced gastric or gastroesophageal junction adenocarcinoma after progression on platinum/fluoropyrimidin…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Study of Comparing of With and Without Sequential Therapy of S-1 [Phase 3]
Phase 3 clinical trial evaluating S-1 with versus without sequential therapy in locally advanced gastric adenocarcinoma; currently recruitin…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 2]
Phase 2 trial evaluating TAS-102 in combination with ramucirumab for advanced, refractory gastric or gastroesophageal junction adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer [Phase 2]
Phase 2 trial investigating tucidinostat with a PD-1 inhibitor and bevacizumab in advanced esophageal and gastric cancers; status is current…
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106) [Phase 3]
A Phase 3 trial evaluating sintilimab plus ramucirumab as first-line treatment for gastric/gastroesophageal junction adenocarcinoma was term…